Hyderabad-based specialty biopharmaceutical manufacturer, Celon Laboratories, Monday announced the launch of an alternative drug – Amphotericin B Emulsion, for the treatment of Mucormycosis, commonly known as a black fungus.
The emulsion-based drug is set to provide much-needed respite to patients reeling under the severe impact of the second wave of Covid-19 and the resultant black fungus, the company said.
Celon will manufacture 10,000 vials per day, which will ensure relief for approximately 6,000 patients monthly.
ALSO RTEAD: 3 suspected deaths due to black fungus in Bengal
Amphotericin B, is crucial to the treatment of Mucormycosis, of which a sudden resurgence is being witnessed off late among Covid-19 patients, across India.
Though Celon has been manufacturing Liposomal Amphotericin B since 2013, market demands were not met due to the unavailability of a critical ingredient sourced from Germany – lipoids. To bypass the bottleneck caused by this sourcing obstacle and increase the production of this medication, Celon developed an alternative, an emulsion-based formulation.
Exhaustively developed by Celon’s in-house R&D team in a record three weeks, the emulsion-based formulation will provide leading hospitals and Covid-19 treatment centers with increased resources to treat the black fungus.
“Celon Labs is deeply committed to supporting the ongoing efforts to combat the Covid-19 pandemic during this deadly second wave and to save as many lives as possible. The emulsion-based formulation is an ideal alternative to Liposomal Amphotericin B to combat the Black Fungus. The company will start supplying the domestic market soon,” said Celon Labs’ Managing Director M. Nagesh Kumar.
ALSO READ: Tamil Nadu ropes in health experts to research on Black fungus
Chairman of Celon, Hocine Sidi expressed his gratitude to employees for achieving this important milestone: “I am delighted to see that Celon Labs has mobilized its talents and expertise to swiftly respond to this pressing medical need. I am grateful to the team at Celon Labs who have made the launch of Amphotericin B Emulsion possible,” he said.
SOURCE-IANS
